BABA vs MHO

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

MHO exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and an exceptionally liquid balance sheet (Current Ratio 7.91). While the stock is significantly undervalued relative to its Graham Number ($193.29) and trades at a low P/E of 9.77, these value drivers are offset by severe fundamental decay. Year-over-year earnings have plummeted by 35.9%, and insider sentiment is heavily bearish with consistent selling from the CEO and CFO. The company is currently a 'value trap' candidate: fundamentally healthy and cheap, but lacking growth catalysts and internal confidence.